Article thumbnail

Profile of Lipid and Protein Autacoids in Diabetic Vitreous Correlates With the Progression of Diabetic Retinopathy

By Michal Laniado Schwartzman, Pavel Iserovich, Katherine Gotlinger, Lars Bellner, Michael W. Dunn, Mauro Sartore, Maria Grazia Pertile, Andrea Leonardi, Sonal Sathe, Ann Beaton, Lynn Trieu and Robert Sack
Topics: Pathophysiology
Publisher: American Diabetes Association
OAI identifier: oai:pubmedcentral.nih.gov:2889779
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2010). 1787omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis.
  2. 5-Lipoxygenase and leukotrienes: transgenic mouse and nuclear targeting studies.
  3. 5-Lipoxygenase, but not 12/15-lipoxygenase, contributes to degeneration of retinal capillaries in a mouse model of diabetic retinopathy.
  4. (1995). a -C-X-Cchemokine, is an angiogenesis inhibitor that suppresses the growth of Lewis lung carcinoma in mice.
  5. A central role for inflammation in the pathogenesis of diabetic retinopathy.
  6. (1999). Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids.
  7. (2008). Antibody protein array analysis of the tear film cytokines. Optom Vis Sci
  8. (2009). Arachidonic acid cytochrome P450 epoxygenase pathway.
  9. (1998). C-C chemokines in the vitreous of patients with proliferative vitreoretinopathy and proliferative diabetic retinopathy. Retina
  10. (2007). Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Exp Diabetes Res
  11. Cytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammation.
  12. (1997). Detection of eicosanoids in epiretinal membranes of patients suffering from proliferative vitreoretinal diseases.
  13. Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy.
  14. Electron impact mass spectroscopic studies on mouse retinal fatty acids: effect of diabetes.
  15. Epoxyeicosatrienoic acid agonist rescues the metabolic syndrome phenotype of HO-2-null mice.
  16. gene transfection attenuates MMP-9 via inhibition of NF-kappabeta in hyperhomocysteinemia.
  17. (2008). Heme oxygenase-1 induction attenuates corneal inflammation and accelerates wound healing after epithelial injury. Invest Ophthalmol Vis Sci
  18. (2006). Herna ´ndez C. Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy. Curr Diabetes Rev
  19. Increased synthesis of leukotrienes in the mouse model of diabetic retinopathy.
  20. (2005). Inflammatory lipid mediators in ischemic retinopathy. Pharmacol Rep
  21. (1990). Leukotrienes and other products of the 5-lipoxygenase pathway: biochemistry and relation to pathobiology in human diseases.
  22. (2005). Lipoxins in the eye and their role in wound healing. Prostaglandins Leukot Essent Fatty Acids
  23. Loss of the antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye disease.
  24. Membrane array characterization of 80 chemokines, cytokines, and growth factors in open- and closed-eye tears: angiogenin and other defense system constituents.
  25. Monocyte chemoattractant protein 1 mediates retinal detachment-induced photoreceptor apoptosis.
  26. (2008). Multiplex bead analysis of vitreous and serum concentrations of inflammatory and proangiogenic factors in diabetic patients.
  27. Multiplex bead analysis of vitreous humor of patients with vitreoretinal disorders.
  28. Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress.
  29. Pharmacotherapy of diseases mediated by 5-lipoxygenase pathway eicosanoids.
  30. Proinflammatory cytokines and angiogenic and antiangiogenic factors in vitreous of patients with proliferative diabetic retinopathy and eales’ disease.
  31. (2008). Resolving inflammation: dual antiinflammatory and pro-resolution lipid mediators. Nat Rev Immunol
  32. Role of leukotrienes revealed by targeted disruption of the 5-lipoxygenase gene.
  33. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
  34. Soluble epoxide hydrolase gene deletion is protective against experimental cerebral ischemia.
  35. (2010). Soluble TNF receptors in vitreoretinal proliferative disease.
  36. (2005). The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Prog Retin Eye Res
  37. Vascular protective effects of cytochrome p450 epoxygenase-derived eicosanoids.
  38. Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: implications for structural differences in macular profiles.